NAPSRX Test/ 1. How are drugs
sorted into therapeutic groups and
classes? (GRADED)
A.A. - --ANSWER->>>>-dosage "of each"
A.C. - --ANSWER->>>>-dosage, "before meals"
AAHP - --ANSWER->>>>-American Association of Health Plans, includes health maintenance
organizations (HMOs), preferred provider organizations (PPO), other forms of managed care, and
utilization review organizations (UROs)
absorption rate - --ANSWER->>>>-the rate at which a drug is taken into a persons bloodstream with in a
specified time period. can vary by person.
AC - --ANSWER->>>>-Anti Cholinergic
;side effect (dry mouth, blurred vision, urinary retention, etc.)
accelerated approval - --ANSWER->>>>- Created in early 1990's, an expedited approval of drugs that
represent a major advance in addressing serious or life-threatening diseases for which no effective
alternative treatments exist.
-Under accelerated approval, the FDA accepts a surrogate endpoint as evidence of effectiveness, and
requires post-marketing studies to confirm the drug's benefits
,A.C.E. inhibitors - --ANSWER->>>>-Angiotensin Converting Enzyme inhibitors.
-A class of drugs used to treat cardiovascular conditions such as hypertension and chronic heart failure
action letters - --ANSWER->>>>-OFFICIAL FDA RESPONSE to NDA. the message may be an approval letter,
approvable letter, or a non-approvable letter
active metabolite - --ANSWER->>>>-A biological active PRODUCT of a medication's metabolism
acute illness - --ANSWER->>>>-a condition or illness that only lasts for a short period of time. (e.g.
common cold)
acute - --ANSWER->>>>-abrupt is onset and short term
AD LIB - --ANSWER->>>>-dosage, "freely"
additions - --ANSWER->>>>-TWO OR MORE medications are used together and the clinical effect is equal
to the sum of their individual effects
adherence - --ANSWER->>>>-overall PROPER USE of medication (time, schedule, technique, etc. )
adjuvant - --ANSWER->>>>-substance that ENHANCES drug/antigen action.
-used with primary therapy
A.D.M.E. - --ANSWER->>>>-Absorption, Distribution, Metabolism, Excretion
-assay that assess impact on human body
adverse drug reaction - --ANSWER->>>>-unwanted, negative consequence from the medication
adverse effect - --ANSWER->>>>-unwanted effect caused by medication
,adverse event - --ANSWER->>>>-UNANTICIPATED EVENT that involves risk for the patient and/or others
A.F. - --ANSWER->>>>-Atrial Fibrillation
-irregular, fast heartbeat causing poor blood flow
affinity - --ANSWER->>>>-MEASURE OF BINDING of an antibody to an antigen
agonist - --ANSWER->>>>-drug that binds with receptors that INITIATES drug rxns.
alignment - --ANSWER->>>>-allocation of client responsibilities
AMA - --ANSWER->>>>-American Medical Association, Chicago, IL
AMCP - --ANSWER->>>>-Academy of Managed Care Pharmacy
-organization for PHARMACY DIRECTORS
APhA - --ANSWER->>>>-American Pharmaceutical Association, 1852
-society of PHARMACISTS, and related personnel
amide - --ANSWER->>>>organic compound, CO=NH2
amyloid - --ANSWER->>>>-extracellular glycoprotein deposits
analgesic - --ANSWER->>>>-pain reliever
analogue - --ANSWER->>>>-similar chem/physical structure
anaphylaxis - --ANSWER->>>>-"foreign substance" causing extreme sensitivity followed by reaction
, ANDA - --ANSWER->>>>-Abbreviated New Drug Application
androgen - --ANSWER->>>>-MALE Reproductive Hormone
angiotensin - --ANSWER->>>>- a peptide, that in angiotensin II form causes vasoconstriction leading to
an increase in blood pressure
antagonist - --ANSWER->>>>-substance that interferes/inhibits physiological activity of another
antibody - --ANSWER->>>>-protein secreted by B plasma cells due to presence of antigen
antigen - --ANSWER->>>>-protein based substance or toxin that causes secretion of antibodies through
immune response
APAP - --ANSWER->>>>-Acetaminophen (Tylenol)
APC - --ANSWER->>>>-Antigen Presenting Cell (dendritic cells, b cells, macrophages)
API - --ANSWER->>>>-Active Pharmaceutical Ingredient.
- the active ingredient that causes the therapeutic effects
approvable letter - --ANSWER->>>>An FDA response to an NDA, listing minor issues to be resolved
before granting marketing approval
AWP - --ANSWER->>>>-Average Wholesale Price
avidity - --ANSWER->>>>Strength of binding, especially the binding of an antibody to an antigen
pharmaceuticals are arguably the most socially important health care product. true or false - --ANSWER-
>>>>true
sorted into therapeutic groups and
classes? (GRADED)
A.A. - --ANSWER->>>>-dosage "of each"
A.C. - --ANSWER->>>>-dosage, "before meals"
AAHP - --ANSWER->>>>-American Association of Health Plans, includes health maintenance
organizations (HMOs), preferred provider organizations (PPO), other forms of managed care, and
utilization review organizations (UROs)
absorption rate - --ANSWER->>>>-the rate at which a drug is taken into a persons bloodstream with in a
specified time period. can vary by person.
AC - --ANSWER->>>>-Anti Cholinergic
;side effect (dry mouth, blurred vision, urinary retention, etc.)
accelerated approval - --ANSWER->>>>- Created in early 1990's, an expedited approval of drugs that
represent a major advance in addressing serious or life-threatening diseases for which no effective
alternative treatments exist.
-Under accelerated approval, the FDA accepts a surrogate endpoint as evidence of effectiveness, and
requires post-marketing studies to confirm the drug's benefits
,A.C.E. inhibitors - --ANSWER->>>>-Angiotensin Converting Enzyme inhibitors.
-A class of drugs used to treat cardiovascular conditions such as hypertension and chronic heart failure
action letters - --ANSWER->>>>-OFFICIAL FDA RESPONSE to NDA. the message may be an approval letter,
approvable letter, or a non-approvable letter
active metabolite - --ANSWER->>>>-A biological active PRODUCT of a medication's metabolism
acute illness - --ANSWER->>>>-a condition or illness that only lasts for a short period of time. (e.g.
common cold)
acute - --ANSWER->>>>-abrupt is onset and short term
AD LIB - --ANSWER->>>>-dosage, "freely"
additions - --ANSWER->>>>-TWO OR MORE medications are used together and the clinical effect is equal
to the sum of their individual effects
adherence - --ANSWER->>>>-overall PROPER USE of medication (time, schedule, technique, etc. )
adjuvant - --ANSWER->>>>-substance that ENHANCES drug/antigen action.
-used with primary therapy
A.D.M.E. - --ANSWER->>>>-Absorption, Distribution, Metabolism, Excretion
-assay that assess impact on human body
adverse drug reaction - --ANSWER->>>>-unwanted, negative consequence from the medication
adverse effect - --ANSWER->>>>-unwanted effect caused by medication
,adverse event - --ANSWER->>>>-UNANTICIPATED EVENT that involves risk for the patient and/or others
A.F. - --ANSWER->>>>-Atrial Fibrillation
-irregular, fast heartbeat causing poor blood flow
affinity - --ANSWER->>>>-MEASURE OF BINDING of an antibody to an antigen
agonist - --ANSWER->>>>-drug that binds with receptors that INITIATES drug rxns.
alignment - --ANSWER->>>>-allocation of client responsibilities
AMA - --ANSWER->>>>-American Medical Association, Chicago, IL
AMCP - --ANSWER->>>>-Academy of Managed Care Pharmacy
-organization for PHARMACY DIRECTORS
APhA - --ANSWER->>>>-American Pharmaceutical Association, 1852
-society of PHARMACISTS, and related personnel
amide - --ANSWER->>>>organic compound, CO=NH2
amyloid - --ANSWER->>>>-extracellular glycoprotein deposits
analgesic - --ANSWER->>>>-pain reliever
analogue - --ANSWER->>>>-similar chem/physical structure
anaphylaxis - --ANSWER->>>>-"foreign substance" causing extreme sensitivity followed by reaction
, ANDA - --ANSWER->>>>-Abbreviated New Drug Application
androgen - --ANSWER->>>>-MALE Reproductive Hormone
angiotensin - --ANSWER->>>>- a peptide, that in angiotensin II form causes vasoconstriction leading to
an increase in blood pressure
antagonist - --ANSWER->>>>-substance that interferes/inhibits physiological activity of another
antibody - --ANSWER->>>>-protein secreted by B plasma cells due to presence of antigen
antigen - --ANSWER->>>>-protein based substance or toxin that causes secretion of antibodies through
immune response
APAP - --ANSWER->>>>-Acetaminophen (Tylenol)
APC - --ANSWER->>>>-Antigen Presenting Cell (dendritic cells, b cells, macrophages)
API - --ANSWER->>>>-Active Pharmaceutical Ingredient.
- the active ingredient that causes the therapeutic effects
approvable letter - --ANSWER->>>>An FDA response to an NDA, listing minor issues to be resolved
before granting marketing approval
AWP - --ANSWER->>>>-Average Wholesale Price
avidity - --ANSWER->>>>Strength of binding, especially the binding of an antibody to an antigen
pharmaceuticals are arguably the most socially important health care product. true or false - --ANSWER-
>>>>true
